Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

Also called NCT04665648

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,500 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04665648
Other papers using this trial's data
  • Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial Journal of the American College of Cardiology, 2026-09-15 DOI, PubMed 42584383

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04665648. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
Acronym
CLEAN
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Nicorandil
Intervention (Drug)
Placebo
Lead sponsor
Fudan University (class: other)

Record details

Record id
cardio:ct-nct04665648
Content hash
784bf8e5d1d9559a43292b26fc9373526ac89726fd373f5594ec9b89f300abd9